Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 20.69% vs -0.06% in Dec 2024

Standalone Net Profit

YoY Growth in quarter ended Dec 2025 is -14.64% vs 26.13% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -10.51% vs 21.43% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is -33.33% vs -21.05% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

373.86

341.64

32.22

9.43%

Other Operating Income

0.00

Total Operating income

373.86

341.64

32.22

9.43%

Raw Material Cost

84.47

155.03

-70.56

-45.51%

Purchase of Finished goods

13.32

5.44

7.88

144.85%

(Increase) / Decrease In Stocks

12.03

-9.66

21.69

224.53%

Employee Cost

61.81

50.10

11.71

23.37%

Power Cost

0.00

Manufacturing Expenses

0.00

0.64

-0.64

-100.00%

Selling and Distribution Expenses

0.00

Other Expenses

91.77

69.75

22.02

31.57%

Total Expenditure (Excl Depreciation)

263.40

271.30

-7.90

-2.91%

Operating Profit (PBDIT) excl Other Income

110.46

70.34

40.12

57.04%

Other Income

4.36

16.29

-11.93

-73.24%

Operating Profit (PBDIT)

114.82

86.63

28.19

32.54%

Interest

0.10

3.56

-3.46

-97.19%

Exceptional Items

0.00

-41.26

41.26

100.00%

Gross Profit (PBDT)

114.72

41.81

72.91

174.38%

Depreciation

5.90

31.20

-25.30

-81.09%

Profit Before Tax

108.82

10.61

98.21

925.64%

Tax

31.23

10.69

20.54

192.14%

Provisions and contingencies

0.00

Profit After Tax

77.59

-0.08

77.67

97,087.50%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

77.59

-0.08

77.67

97,087.50%

Equity Capital

16.60

87.22

-70.62

-80.97%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

46.74

-0.00

46.74

Diluted Earnings per share

46.74

0.00

46.74

Operating Profit Margin (Excl OI)

29.55%

20.59%

0.00

8.96%

Gross Profit Margin

30.69%

12.24%

0.00

18.45%

PAT Margin

20.75%

-0.02%

0.00

20.77%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 373.86 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 15.06% vs -4.08% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 20.69% vs -0.06% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 77.59 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -12.37% vs 33.79% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -14.64% vs 26.13% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 110.46 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -8.16% vs 33.13% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -10.51% vs 21.43% in Dec 2024

Quarterly - Interest

Interest 0.10 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -16.67% vs 0.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -33.33% vs -21.05% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 29.55%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024